CVS Health Corporation (CVS) Financial Statements (2024 and earlier)
Company Profile
Business Address |
ONE CVS DR. WOONSOCKET, RI 02895 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 5912 - Drug Stores and Proprietary Stores (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 13,089 | 11,455 | 16,188 | 16,887 | 17,720 | 15,723 | |||
Cash and cash equivalents | 9,801 | 8,196 | 13,043 | 13,807 | 14,618 | 12,945 | |||
Short-term investments | 3,288 | 3,259 | 3,145 | 3,080 | 3,102 | 2,778 | |||
Receivables | 32,217 | 35,227 | 32,927 | 29,546 | 28,331 | 27,276 | |||
Inventory, net of allowances, customer advances and progress billings | 16,346 | 18,025 | 17,954 | 17,291 | 18,263 | 19,090 | |||
Inventory | 16,346 | 18,025 | 17,954 | 17,291 | 18,263 | 19,090 | |||
Disposal group, including discontinued operation | 620 | 625 | 908 | ||||||
Other current assets | 5,821 | 3,151 | 3,074 | 3,412 | 3,767 | 2,685 | |||
Total current assets: | 67,473 | 67,858 | 70,143 | 67,756 | 68,706 | 65,682 | |||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 1,229 | ||||||||
Operating lease, right-of-use asset | 17,045 | 17,252 | 17,564 | 17,703 | 17,660 | 17,872 | |||
Property, plant and equipment | 13,022 | 13,001 | 12,872 | 12,873 | |||||
Long-term investments and receivables | 24,074 | 23,019 | 21,667 | 22,114 | 21,612 | 21,096 | |||
Long-term investments | 24,074 | 23,019 | 21,667 | 22,114 | 21,612 | 21,096 | |||
Intangible assets, net (including goodwill) | 120,042 | 120,506 | 120,885 | 121,378 | 110,425 | 102,904 | |||
Goodwill | 91,272 | 91,272 | 91,261 | 91,260 | 84,057 | 78,150 | |||
Intangible assets, net (excluding goodwill) | 28,770 | 29,234 | 29,624 | 30,118 | 26,368 | 24,754 | |||
Restricted cash and investments | 255 | 239 | 236 | 233 | 230 | 216 | |||
Other noncurrent assets | 4,801 | 4,660 | 4,825 | 4,852 | 4,824 | 4,620 | |||
Other undisclosed noncurrent assets | 16,053 | 14,965 | 2,964 | 3,034 | 3,001 | 3,012 | |||
Total noncurrent assets: | 182,270 | 181,870 | 181,163 | 182,315 | 170,624 | 162,593 | |||
TOTAL ASSETS: | 249,743 | 249,728 | 251,306 | 250,071 | 239,330 | 228,275 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 36,067 | 37,086 | 37,445 | 36,198 | 34,042 | 33,583 | |||
Accounts payable | 13,717 | 14,897 | 14,874 | 13,367 | 12,527 | 14,838 | |||
Accrued liabilities | 22,350 | 22,189 | 22,571 | 22,831 | 21,515 | 18,745 | |||
Deferred revenue | 117 | 149 | 167 | 161 | 136 | 71 | |||
Debt | 6,450 | 2,972 | 2,132 | 2,402 | 1,778 | 1,778 | |||
Disposal group, including discontinued operation | 208 | 213 | 228 | ||||||
Other undisclosed current liabilities | 40,685 | 38,982 | 41,809 | 40,237 | 38,885 | 34,076 | |||
Total current liabilities: | 83,319 | 79,189 | 81,553 | 79,206 | 75,054 | 69,736 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation, including: | 57,694 | 58,638 | 59,782 | 61,419 | 56,450 | 50,476 | |||
Finance lease, liability | 1,325 | 1,406 | |||||||
Other undisclosed long-term debt and lease obligation | 57,694 | 57,313 | 59,782 | 61,419 | 56,450 | 49,070 | |||
Liabilities, other than long-term debt | 26,131 | 26,556 | 26,928 | 27,518 | 27,337 | 27,412 | |||
Deferred income tax liabilities | 4,184 | 4,311 | 4,250 | 4,588 | 4,095 | 3,880 | |||
Other liabilities | 6,205 | 6,211 | 6,237 | 6,321 | 6,671 | 6,732 | |||
Operating lease, liability | 15,742 | 16,034 | 16,441 | 16,609 | 16,571 | 16,800 | |||
Other undisclosed noncurrent liabilities | 8,449 | 8,709 | 8,533 | 8,926 | 8,909 | 9,336 | |||
Total noncurrent liabilities: | 92,274 | 93,903 | 95,243 | 97,863 | 92,696 | 87,224 | |||
Total liabilities: | 175,593 | 173,092 | 176,796 | 177,069 | 167,750 | 156,960 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 73,968 | 76,461 | 74,337 | 72,726 | 71,382 | 71,015 | |||
Common stock | 18 | 18 | 18 | 18 | 18 | 18 | |||
Treasury stock, value | (36,773) | (33,838) | (33,831) | (33,933) | (33,802) | (31,858) | |||
Accumulated other comprehensive loss | (341) | (297) | (1,004) | (858) | (875) | (1,465) | |||
Retained earnings | 61,873 | 61,604 | 60,343 | 58,868 | 57,753 | 56,145 | |||
Other undisclosed equity, attributable to parent | 49,191 | 48,974 | 48,811 | 48,631 | 48,288 | 48,175 | |||
Equity, attributable to noncontrolling interest | 182 | 175 | 173 | 276 | 198 | 300 | |||
Total equity: | 74,150 | 76,636 | 74,510 | 73,002 | 71,580 | 71,315 | |||
TOTAL LIABILITIES AND EQUITY: | 249,743 | 249,728 | 251,306 | 250,071 | 239,330 | 228,275 |
Income Statement (P&L) ($ in millions)Annual | Quarterly
6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 88,437 | 93,813 | 89,764 | 88,921 | 85,278 | 83,846 | ||
Premiums earned, net | 30,391 | 25,075 | 24,657 | 25,108 | 24,352 | 21,436 | ||
Cost of revenue | (75,208) | (52,151) | (85,460) | (84,549) | (81,038) | (78,686) | ||
Cost of goods and services sold | (48,073) | (57,419) | (54,688) | (53,536) | (51,455) | |||
Policyholder benefits and claims incurred, net | ||||||||
Gross profit: | 13,229 | 41,662 | 4,304 | 4,372 | 4,240 | 5,160 | ||
Operating expenses | (10,958) | (38,289) | (614) | (1,138) | (794) | (1,542) | ||
Operating income: | 2,271 | 3,373 | 3,690 | 3,234 | 3,446 | 3,618 | ||
Nonoperating income (Other Nonoperating income) | 25 | 22 | 22 | 22 | 22 | 43 | ||
Interest and debt expense | (716) | (690) | (693) | (686) | (589) | (552) | ||
Income from continuing operations before income taxes: | 1,580 | 2,705 | 3,019 | 2,570 | 2,879 | 3,109 | ||
Income tax expense | (456) | (658) | (754) | (656) | (737) | (809) | ||
Net income: | 1,124 | 2,047 | 2,265 | 1,914 | 2,142 | 2,300 | ||
Net income (loss) attributable to noncontrolling interest | (11) | (1) | (4) | (13) | (6) | 2 | ||
Net income available to common stockholders, diluted: | 1,113 | 2,046 | 2,261 | 1,901 | 2,136 | 2,302 |
Comprehensive Income ($ in millions)Annual | Quarterly
6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | ||
---|---|---|---|---|---|---|---|---|
Net income: | 1,124 | 2,047 | 2,265 | 1,914 | 2,142 | 2,300 | ||
Other comprehensive income (loss) | (44) | 707 | (146) | 17 | 389 | 144 | ||
Comprehensive income: | 1,080 | 2,754 | 2,119 | 1,931 | 2,531 | 2,444 | ||
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (11) | (1) | (4) | (13) | (6) | 2 | ||
Comprehensive income, net of tax, attributable to parent: | 1,069 | 2,753 | 2,115 | 1,918 | 2,525 | 2,446 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.